Sun and Taro trade charges in merger dispute
This article was originally published in Scrip
Executive Summary
The merger dispute between Sun Pharmaceutical Industriesand Taro Pharmaceutical Industriesappears to be headed back to court, after both sides rejected each other's proposals to resolve the imbroglio.